Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region

Abstract:  Based on the presence of an abundant inflammatory infiltrate, expression of a broad spectrum of cytokines and the professional antigen presenting phenotype of Hodgkin Reed‐Sternberg cells it can be anticipated that immunological mechanisms play a major role in the pathogenesis of Hodgkin's lymphoma (HL). Genetic susceptibility to HL probably relates to functionality of the immune system and the large number of associations with the human leukocyte antigen (HLA) region in family and population‐based studies supports this relation. In Epstein–Barr virus (EBV) positive HL cases, which usually demonstrate HLA class I expression, HRS cells should be able to present EBV derived antigenic peptides and trigger the immune system. This process depends on the affinity of the HLA binding groove for binding immunogenic peptides and thus on the HLA alleles. It can be anticipated that certain combinations of alleles predispose to or protect from the development of EBV positive HL. In EBV negative HL cases other antigenic peptides, related to malignant transformation, in combination with other HLA alleles may be involved. In addition, differential attraction and activation of inflammatory cells may influence HL subtype. In this article, possible roles of HLA in HL pathogenesis are explored and genetic associations of HLA with HL are reviewed and commented on.

[1]  A. Rickinson,et al.  Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. , 1997, Journal of immunology.

[2]  A. Videbaek Familial Hodgkin's disease. , 1955, Acta haematologica.

[3]  J. Goedert,et al.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[4]  D. Motto,et al.  ADAMTS13 Binds VWF Via its C-Terminal CUB2 Domain. , 2004 .

[5]  C Dosne Pasqualini,et al.  The HLA system. , 1979, Medicina.

[6]  J. Dausset,et al.  HLA and Susceptibility to Hodgkin's Disease , 1983, Immunological reviews.

[7]  A. van den Berg,et al.  Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  E. Bloemena,et al.  Identification and prevalence of CD8+ T‐cell responses directed against Epstein‐Barr virus‐encoded latent membrane protein 1 and latent membrane protein 2 , 2002, International journal of cancer.

[9]  P. Boffetta,et al.  Familial Hodgkin's disease: a disease of young adulthood? , 1997, Annals of Hematology.

[10]  A. van den Berg,et al.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. , 1999, The American journal of pathology.

[11]  F. Herrmann,et al.  Hodgkin's disease: a tumor with disturbed immunological pathways. , 1997, Immunology today.

[12]  Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. , 1999, Nature.

[13]  R. Jarrett Viruses and Hodgkin's lymphoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  T. Landberg,et al.  HLA antigens in Hodgkin's disease of very long survival. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[15]  S. Pileri,et al.  Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases , 2003, Modern Pathology.

[16]  W. Klitz,et al.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. , 1992, Journal of immunology.

[17]  S. Hsu,et al.  The nature of Reed-Sternberg cells: phenotype, genotype, and other properties. , 1994, Critical reviews in oncogenesis.

[18]  Y. Shugart,et al.  A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden , 2000, Human Genetics.

[19]  W. Blattner,et al.  HLA antigens in familial Hodgkin's disease , 1979, International journal of cancer.

[20]  Jose M Garcia,et al.  Simultaneous Hodgkin's disease in three siblings with identical HLA‐genotype , 1980, Cancer.

[21]  K. Karube,et al.  Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: Classical Hodgkin lymphoma vs. Hodgkin‐like ATLL , 2003, International journal of cancer.

[22]  D. Osoba,et al.  The prognostic value of HLA phenotypes in Hodgkin's disease , 1980, Cancer.

[23]  P. Murray,et al.  Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. , 1998, Blood.

[24]  A. van den Berg,et al.  Immune reactions in classical Hodgkin's lymphoma. , 1999, Seminars in hematology.

[25]  J. Dausset,et al.  HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs. , 1980, European journal of cancer.

[26]  G. M. Taylor,et al.  Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated. , 1996, Leukemia.

[27]  S. Bigner,et al.  Familial Hodgkin's disease a clinical and laboratory investigation , 1987, Cancer.

[28]  T. Lister,et al.  Association of HLA-DPB with Hodgkin's disease , 1992, The Lancet.

[29]  H. Heslop,et al.  Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. , 2002, Cancer research.

[30]  L. Young,et al.  Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. , 1998, Blood.

[31]  E. Perlin,et al.  Another Observation of Increased Frequency of HL-A 5 and HL-A 8 in Hodgkin’s Disease , 1975 .

[32]  B. Nathwani,et al.  Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. , 1995, The New England journal of medicine.

[33]  T. Lister,et al.  A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. , 1994, Cancer research.

[34]  M. Carrington,et al.  HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. , 2002, Blood.

[35]  C. A. Doan,et al.  Studies in Hodgkin's syndrome. XII. Hereditary and epidemiologic espects. , 1957, Annals of internal medicine.

[36]  M. Björkholm,et al.  A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease. , 2008, Tissue antigens.

[37]  G. M. Taylor,et al.  Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes , 1999, British Journal of Cancer.

[38]  P. Brousset,et al.  Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data , 1997, International journal of cancer.

[39]  J. Lukens,et al.  Hodgkin's disease in three children from an Amish kindred. , 1972, The Journal of pediatrics.

[40]  T. Lister,et al.  HLA-DP BASED RESISTANCE TO HODGKIN'S DISEASE , 1989, The Lancet.

[41]  T. Mak,et al.  The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.

[42]  W. Klitz,et al.  Localization of predisposition to Hodgkin disease in the HLA class II region. , 1994, American journal of human genetics.

[43]  S. Grufferman,et al.  Clustering and aggregation of exposures in Hodgkin's disease , 1977, Cancer.

[44]  A. Chakravarti,et al.  Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance , 1986, Genetic epidemiology.

[45]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[46]  S. Glaser,et al.  Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. , 2002, Leukemia research.

[47]  M. King,et al.  Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. , 1983, Human immunology.

[48]  J. Barnard,et al.  Hla in familial hodgkin's disease. Results and a new hypothesis , 1977, International journal of cancer.

[49]  Nawal M. El‐Kholy,et al.  The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma , 1985, International journal of cancer.

[50]  E. Creagan,et al.  Familial Hodgkin's disease. , 1972, Lancet.

[51]  J. Hansen,et al.  HLA and MLC typing in patients with Hodgkin's disease. , 1977, Progress in clinical and biological research.

[52]  L. Craver,et al.  Familial Hodgkin's disease: its significance and implications. , 1959, Annals of internal medicine.

[53]  L. Liau,et al.  Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done , 2004 .

[54]  A. Berg Immune dysfunction in classical Hodgkin lymphoma. , 2004 .

[55]  R. Conte,et al.  HLA IN FAMILIAL HODGKIN'S DISEASE , 1983, Journal of immunogenetics.

[56]  Rong Wang,et al.  The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. , 2001, Trends in immunology.

[57]  J. Klein,et al.  The HLA system. First of two parts. , 2000, The New England journal of medicine.

[58]  J. Baak,et al.  Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. , 1996, Blood.

[59]  G. M. Taylor,et al.  Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.